Insider buying
~$31K10K sh @ $3.08
Traded Jul 31, 2025 · filed 4 days later
An Anixa Biosciences director paid $31K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jul 11, 2025 · Filed Jul 14, 2025
The CEO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$15,750
Shares × reported transaction price
<$25K
+0.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 1 month
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
This purchase equals less than 1% of the CEO's reported total pay for fiscal 2024 ($3.48M)
Purchase value ÷ the CEO's total from the Summary Compensation Table, as tagged in the pay versus performance table of the company's proxy statement (DEF 14A), filed 2026-01-28. The proxy names Dr. Kumar as CEO for that year. A size comparison, not a judgement
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +4.2% | +1.1% | +3.1% |
| 30 days | −7.2% | +3.7% | −10.9% |
| 90 days | +41.3% | +6.6% | +34.7% |
| 180 days | −1.3% | +11.7% | −13.0% |
| 365 days | +9.4% | +21.3% | −11.9% |
Past results only. Not a forecast.
Insider buying
Traded Jul 31, 2025 · filed 4 days later
An Anixa Biosciences director paid $31K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
Traded Jul 30, 2025 · filed 1 day later
The CEO of Anixa Biosciences paid $16K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month.
Insider buying
Traded Jul 18, 2025 · filed 3 days later
An Anixa Biosciences director paid $17K out of pocket for Anixa Biosciences shares. 2 other people at Anixa Biosciences bought some too, in the same month. It was the first purchase in 6 months.
Amit Kumar, Chief Executive Officer's past purchases, 90 days after disclosure: 10 buys, median −6.0 pts vs S&P 500, beat it 3 of 10 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.